Transplant
From the Journals
Nonmyeloablative conditioning carries lowers infection risk in patients with AML
Patients who received myeloablative conditioning tended to develop infections sooner.
From the Journals
Pediatric HSCT recipients still risking sunburn
Pediatric hematopoietic stem cell transplant recipients are practicing more sun-protection behaviors, but they still tan and sunburn as much as...
From the Journals
Progressive myeloma after induction? Go straight to transplant
The study did not find a survival advantage for patients who had salvage therapy to deepen their responses before moving on to transplant.
From the Journals
Novel conditioning regimen shows benefit for beta-thalassemia major
The transplant regimen significantly reduced graft-versus-host disease following unrelated-donor hematopoietic stem cell transplant.
Guidelines
Guidelines update donor selection criteria for HSCT
The evidence-based guidelines provide recommendations for selecting adult donors and cord blood units for allogeneic hematopoietic stem cell...
From the Journals
Recombinant vaccine cut herpes zoster rate in immunocompromised patients
In a randomized clinical trial of 1,846 adults who had undergone autologous HSCT, herpes zoster cases were seen in 49 and 136 individuals in the...
Conference Coverage
Femoral head decompression relieves SCD hip pain
FORT LAUDERDALE, FLA. – Femoral head core decompression with bone marrow aspirate concentrate appears to reduce hip joint pain for sickle cell...
Conference Coverage
AML variants before transplant signal need for aggressive therapy
AMSTERDAM – Patients who had genomic evidence of a lingering AML variant had worse posttransplant outcomes when they underwent reduced-intensity...
Conference Coverage
Survival exceeds 90% in transplant for SCD
FORT LAUDERDALE, FLA. — A pilot study has shown one-year overall survival rates exceeding 90% for bone marrow transplants in adults with severe...
News
FDA approves first drug for steroid-refractory acute GVHD
Ruxolitinib will be made available to appropriate patients immediately, according to Incyte.
Conference Coverage
More abnormal cells linked to poorer ASCT outcomes in MDS
NEWPORT BEACH, CALIF. – Patients with more than 60% cytogenetically abnormal cells at transplant had inferior overall survival and relapse-free...